We are live on
!
Find out more
SCM
Silverarc Capital Management Portfolio holdings
AUM
$849M
1-Year Est. Return
470.8%
This Fund
S&P 500
This Quarter
Est. Return
+37.22%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$236M
AUM Growth
+$22.4M
(+11%)
Cap. Flow
-$1.25M
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
41.83%
Holding
92
New
24
Increased
26
Reduced
17
Closed
14
Top Buys
| 1 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
+$7.19M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$6.21M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
+$5.34M |
| 4 |
Pliant Therapeutics
PLRX
|
+$4.01M |
| 5 |
Nkarta
NKTX
|
+$3.6M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$9.29M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$5.87M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$4.91M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$4.34M |
| 5 |
Biogen
BIIB
|
+$4.25M |
Sector Composition
| 1 | Healthcare | 96.41% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLU
1
DELISTED
BELLUS Health Inc.
BLU
| $17.5M | 7.42% |
1,655,775
+92,818
| +6% | +$986K |
|
2
Veracyte
VCYT
$4.68B
| $11.1M | 4.69% |
665,854
-52,935
| -7% | -$1.19M |
|
|
AKRO
3
DELISTED
Akero Therapeutics
AKRO
| $10.2M | 4.33% |
300,000
+39,675
| +15% | +$607K |
|
|
MORF
4
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.18M | 3.89% |
324,421
-94,239
| -23% | -$2.63M |
|
5
Cogent Biosciences
COGT
$6.67B
| $9.05M | 3.84% |
606,608
-214,346
| -26% | -$2.94M |
|
|
PSTX
6
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $9.02M | 3.82% |
2,554,277
+2,173,671
| +571% | +$7.19M |
|
7
Xenon Pharmaceuticals
XENE
$6.49B
| $8.88M | 3.77% |
245,992
+13,362
| +6% | +$480K |
|
8
Aclaris Therapeutics
ACRS
$764M
| $8.56M | 3.63% |
543,776
+4,231
| +0.8% | +$66.7K |
|
|
VRAY
9
DELISTED
ViewRay, Inc.
VRAY
| $8.46M | 3.59% |
2,324,066
+1,591,326
| +217% | +$5.34M |
|
|
MRSN
10
DELISTED
Mersana Therapeutics
MRSN
| $6.72M | 2.85% |
39,763
+5,763
| +17% | +$937K |
|
11
Prothena Corp
PRTA
$446M
| $6.67M | 2.83% |
+110,000
| New | +$3.48M |
|
|
12
Alnylam Pharmaceuticals
ALNY
$37.4B
| $6.51M | 2.76% |
+32,545
| New | +$6.21M |
|
|
ITCI
13
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.33M | 2.69% |
136,126
-177,836
| -57% | -$9.29M |
|
|
APEN
14
DELISTED
Apollo Endosurgery, Inc.
APEN
| $6.26M | 2.66% |
1,136,206
+61,327
| +6% | +$340K |
|
|
MRUS
15
DELISTED
Merus
MRUS
| $5.91M | 2.51% |
295,136
-173,977
| -37% | -$4.15M |
|
16
Cerus
CERS
$633M
| $5.82M | 2.47% |
1,616,459
-477,402
| -23% | -$2.28M |
|
|
CTIC
17
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.72M | 2.43% |
983,516
-396,595
| -29% | -$2.47M |
|
18
Insmed
INSM
$23.6B
| $4.83M | 2.05% |
224,016
+11,534
| +5% | +$277K |
|
|
19
Nkarta
NKTX
$185M
| $4.77M | 2.02% |
362,377
+251,614
| +227% | +$3.6M |
|
|
20
Pliant Therapeutics
PLRX
$68.7M
| $4.38M | 1.86% |
+209,822
| New | +$4.01M |
|
21
Acumen Pharmaceuticals
ABOS
$165M
| $4.21M | 1.79% |
+420,000
| New | +$2.41M |
|
22
Krystal Biotech
KRYS
$10.1B
| $3.95M | 1.67% |
56,645
-48,632
| -46% | -$3.51M |
|
23
Oric Pharmaceuticals
ORIC
$1.13B
| $3.87M | 1.64% |
1,208,992
+126,688
| +12% | +$507K |
|
24
Vertex Pharmaceuticals
VRTX
$121B
| $3.21M | 1.36% |
11,105
+691
| +7% | +$199K |
|
|
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.18M | 1.35% |
+177,364
| New | +$2.33M |
|
Similar funds
BOTOTLSJU
EFG
LA
EPIMS
CFP
USAA
OMC
AIA